Publication | Closed Access

Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: A lead compound that attenuates vascular leak

Molecular PharmacologySignal TransductionMolecular PhysiologyBiochemistryMedicineVascular PharmacologyReceptor Tyrosine KinaseVascular LeakNovel Bioavailable InhibitorVascular BiologyPharmacologyLead CompoundCell SignalingProtein PhosphorylationDrug Discovery